BioMS Medical Initiates Enrollment in Pivotal U.S. Phase III Multiple Sclerosis Trial RedNova Wed, 06 Jun 2007 9:07 AM PDT EDMONTON, June 5 /PRNewswire-FirstCall/ -- BioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), today announced that the first patients have been enrolled in MAESTRO-03, its U.S.

Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis RedNova Wed, 06 Jun 2007 9:07 AM PDT Acorda Therapeutics (Nasdaq: ACOR) announced today that it has begun a second Phase 3 clinical study of Fampridine-SR in multiple sclerosis (MS), with the randomization of its first patient into the treatment phase of the study.

Sugar supplement may treat immune disease New Scientist Wed, 06 Jun 2007 10:19 AM PDT A form of sugar commonly used to treat osteoarthritis could help treat autoimmune conditions such as multiple sclerosis

Largest ever study of genetics of common diseases published today EurekAlert! Wed, 06 Jun 2007 10:08 AM PDT The Wellcome Trust Case Control Consortium, the largest ever study of the genetics behind common diseases such as diabetes, rheumatoid arthritis and coronary heart disease, today publishes its results in the journals Nature and Nature Genetics.

Hands-free mouse helps disabled nose through the net
CBC Wed, 06 Jun 2007 9:02 AM PDT
Computer users who can't move their hands are testing a device that allows them to point and click using their nose.